House’s Hyde Amendment Vote Advances Abortion Justice and Racial Equity
By Destiny Lopez,
Truthout
| 08. 12. 2021
Congress just took a historic step forward for racial, economic and reproductive justice 45 years in the making. Every year since 1976, lawmakers have chosen to deny insurance coverage of abortion to people working to make ends meet by adding a policy known as the Hyde Amendment to federal spending bills. But now, for the first time since Hyde’s inception, the U.S House passed a budget without this harmful policy.
The House vote marks a bold rejection of decades of injustice against women, people of color and people living paycheck to paycheck, among others targeted by Hyde. Now, we turn our attention to the U.S. Senate.
The push to end Hyde is happening at a pivotal moment. As a country, we are finally beginning to critically reckon with policies that hurt people of color, whether they shape our chances of surviving a pandemic or an interaction with police. Bans on abortion coverage are driven by the same forces motivating state-sanctioned violence and even voting restrictions. Each aims to control the lives of Black, Brown and other people of color, especially...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...